Featured
Mezzetta recalls peperoncini jars after pest found in jar
Child Vaccines Sep 29, 2026
Lunch Nutrition Sep 28, 2026
Germ Control Sep 26, 2026
Mezzetta recalls 32-ounce Golden Greek Peperoncini jars after pest found in a single batch, triggering...
Football players face a fourfold higher risk of developing ALS, according to a 2021 study,...
Australia's latest health literacy push, aged‑care shortages and heated tobacco policy debates in this week’s...
Read our latest Germ Control articles.
The USS Abraham Lincoln carrier strike group reported eight suicide attempts during a 10-month deployment,...
Expert discusses TDP-43 role in ALS research, a protein present in 97% of ALS patients,...
Oveporexton shows symptom improvement in narcolepsy type 1, improving wakefulness and quality of life.
Mezzetta recalls 32-ounce Golden Greek Peperoncini jars after pest found in a single batch, triggering a voluntary recall due to consumer video.
Mezzetta recalls 32-ounce Golden Greek Peperoncini jars after pest found in a single batch, triggering a voluntary recall due to...
Ground cinnamon product recalled due to high lead levels found in testing, affecting six states including New York and Texas.
The USS Abraham Lincoln carrier strike group reported eight suicide attempts during a 10-month deployment, revealing mental health struggles among...
AI coding dispute where insurers blame rising costs on AI tools flagging complex diagnoses, while hospitals cite sicker patients.
One measles-related death has occurred in the U.S. this year, but the CDC has not disclosed the identity or location...
Addressing social determinants can improve stroke prevention in underserved communities, reducing disparities and saving lives.
Acupuncture may improve Parkinson's disease symptoms, including motor function and quality of life, according to a new study.
Neurologists discuss cluster headache treatments and emerging approaches for chronic cluster headache patients.
New treatments emerge for Alzheimer's agitation, moving beyond off-label drug use with modest benefits.
Denali Therapeutics halted the SAR443820 trial after a phase 2 study failed to slow functional decline in adults with ALS,...